| Literature DB >> 33650082 |
Gal Ben-Haim1,2, Amit Zabatani3,4, David Orion5,4, Eyal Leshem6,4, Avinoah Irony7,4, Eldad Katorza8,4.
Abstract
The emergence of Covid-19 has caused a pandemic and is a major public health concern. Covid-19 has fundamentally challenged the global health care system in all aspects. However, there is a growing concern for the subsequent detrimental effects of continuing delays or adjustments on time-dependent treatments for Covid-19 negative patients. Patients arriving to the ED with STEMIs and acute CVA are currently presumed to have delays due to Covid-19 related concerns. The objective of this paper is to evaluate the implications of the Covid-19 pandemic on non-Covid19 patients in emergency care settings. We conducted a retrospective study from February 2020 to April 2020 and compared this to a parallel period in 2019 to assess the impact of the Covid-19 pandemic on three distinct non-Covid-19 ED diagnosis that require immediate intervention. Our primary outcome measures were time to primary PCI in acute STEMI, time to fibrinolysis in acute CVA, and time to femoral hip fracture correction surgery. Our secondary outcome measure included a composite outcome of length of stay in hospital and mortality. From 1 February 2020 to 30 April 2020, the total referrals to ED diagnosed with STEMI, Hip fracture and CVA of which required intervention were 197 within Covid-19 group 2020 compared to 250 in the control group 2019. Mean duration to intervention (PCI, surgery and tPA, respectively) did not differ between COVID-19 group and 2019 group. Among femoral hip fracture patients', the referral numbers to ED were significantly lower in Covid-19 era (p = 0.040) and the hospitalization stay was significantly shorter (p = 0.003). Among CVA patients', we found statistical differences among the number of referrals and the patients' age. Coping with the Covid-19 pandemic presents a challenge for the general healthcare system. Our results suggest that with proper management, despite the obstacles of isolation policies and social distancing, any negative impact on the quality of health care for the non-Covid-19 patients can be minimized in the emergency department setting.Entities:
Keywords: CVA; Femoral fracture; Non-covid-19; Quality indicator; STEMI
Mesh:
Year: 2021 PMID: 33650082 PMCID: PMC7920545 DOI: 10.1007/s11739-021-02680-5
Source DB: PubMed Journal: Intern Emerg Med ISSN: 1828-0447 Impact factor: 3.397
Summarize data characteristics of 128 patients diagnosed with ST-elevation myocardial infarction require urgent primary coronary intervention and comparison between the two groups: COVID- 19 period to the control group from 2019
| Covid19 | Control | |||
|---|---|---|---|---|
| No. of cases (n) | 0.500 | |||
| Age (mean ± SD) | 63 ± 10.6 | 64 ± 12 | 0.732 | |
| Gender | Female (%) | 16 (30) | 14 (16) | 0.418 |
| Male (%) | 44 (70) | 54 (84) | ||
| Length of stay (days) | 5.83 ± 3.3 | 5.50 ± 5.3 | 0.676 | |
| Door to intervention (Minutes) | 85 ± 214 | 46 ± 34.2 | 0.072 | |
| Mortality | No mortality (n) | 57 | 65 | 0.599 |
| In hospital mortality (n) | 3 | 3 | ||
| Out hospital mortality (n) | 0 | 0 |
All data are presented in the form of mean (Standard deviation) unless otherwise specified
Fig. 1Demonstrate a population pyramid histograms concerning the three quality measures: acute ST-segment elevation myocardial infarction, acute femur fracture and acute cerebral ischemia, comparing both parallel periods: covid-19 group and the control group. a Represent time to percutaneous coronary intervention in minutes by frequency cases comparing both parallel periods. The dash line represents the goal established to reduce mortality and morbidity (a time-to-PCI ≤ 90 min). b Represent the time to femoral surgery in hours by frequency cases comparing both parallel periods. The dash line represents the goal established to reduce mortality and morbidity (a time-to-surgery ≤ 48 h). c Demonstrate a population frequency and length of hospitalization in days after femoral repair. d Represent the time to tissue plasminogen activator (thrombolysis) in hours by frequency cases while comparing both parallel periods in acute cerebral ischemia. The dash line represents the goal established to reduce mortality and morbidity (a time-to-tPa ≤ 4.5 h). e Demonstrate a population pyramid by histogram frequency demonstrate length of hospitalization in days while comparing both parallel periods in acute cerebral ischemia
Summarize the characteristics data regards 271 diagnosed with femoral fracture and required surgery of both groups and comparison between the COVID- 19 periods of time to the control group in 2019. All data are presented in the form of mean (Standard deviation) unless otherwise specified
| No. of cases (n) | COVID-19 | Control | ||
|---|---|---|---|---|
| Gender | Female (%) | 87 (73) | 98 (64) | 0.130 |
| Male (%) | 32 (27) | 54 (36) | ||
| Age (mean) | 83 ± 8 | 83 ± 8 | 0.895 | |
| Length of stay (days) | 14 | 19 | ||
| Time to surgery (hours) | 30.96 ± 32 | 31.74 ± 30 | 0.092 | |
| Mortality | No mortality | 114 | 148 | 0.141 |
| In hospital mortality | 3 | 0 | ||
| Out hospital mortality | 2 | 4 | ||
Summarize the characteristics data regards 48 diagnosed with acute cerebral ischemic stroke required urgent Recombinant tissue plasminogen activator and comparison between the COVID- 19 periods of time to the control group from 2019. All data are presented in the form of mean (standard deviation) unless otherwise specified
| No. of cases (n) | Covid19 | Control | ||
|---|---|---|---|---|
| 18 | 30 | |||
| Gender | Female (%) | 9 (50) | 11 (37) | 0.252 |
| Male (%) | 9 (50) | 19 (63) | ||
| Age (mean) | 80 ± 9 | 72 ± 14 | ||
| Length of stay (days) | 8 ± 6 | 9 ± 7 | 0.408 | |
| Time to intervention (hours) | 3.06 ± 1.5 | 2.77 ± 1 | 0.409 | |
| Mortality | No mortality | 15 | 29 | 0.055 |
| In hospital mortality | 3 | 0 | ||
| Out hospital mortality | 0 | 1 | ||